Physician Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Physician Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.9K	Buy	22 +6	+38%	+$1.83K	﹤0.01%	939
2026 Q1	$4.01K	Buy	16 +2	+14%	+$498	﹤0.01%	1086
2025 Q4	$3.85K	Sell	14 -48	-77%	-$13.1K	﹤0.01%	1061
2025 Q3	$16.3K	Buy	62 +59	+1,967%	+$14.3K	﹤0.01%	632
2025 Q2	$657	Sell	3 -2	-40%	-$428	﹤0.01%	1632
2025 Q1	$1.12K	Buy	5 +3	+150%	+$827	﹤0.01%	998
2024 Q4	$656	Buy	+2	New	+$629	﹤0.01%	1064

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Physician Wealth Advisors's WST Position: Q2 2026 in Review

Physician Wealth Advisors increased its West Pharmaceutical (WST) stake by 38% in Q2 2026, buying an estimated $1.83K and bringing the position to 22 shares worth $7.9K. The position accounts for ﹤0.01% of the portfolio, ranked #939.

Physician Wealth Advisors first reported a position in WST in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.3K in Q3 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Physician Wealth Advisors held 22 shares of West Pharmaceutical worth $7.9K as of Q2 2026.
Physician Wealth Advisors bought 6 West Pharmaceutical shares in Q2 2026, an estimated $1.83K.
West Pharmaceutical made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #939 holding.
Physician Wealth Advisors first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
Physician Wealth Advisors's West Pharmaceutical position peaked at $16.3K in Q3 2025.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.